Cargando…

Herpesviridae reactivation for poor outcome in ARDS patients with ECMO: criminal or witness?

Detalles Bibliográficos
Autores principales:	Huang, Huixue, He, Hangyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987285/ https://www.ncbi.nlm.nih.gov/pubmed/31993803 http://dx.doi.org/10.1186/s13613-020-0626-4

Ejemplares similares

Response to Huang et al. “Herpesviridae reactivation for poor outcome in ARDS patients with ECMO: criminal or witness?”
por: Hraiech, Sami, et al.
Publicado: (2020)

Herpesviridae systemic reactivation in patients with COVID-19-associated ARDS
por: Reizine, F., et al.
Publicado: (2022)

Why driving pressure is not associated with the mortality in non-ARDS patients?
por: Huang, Huixue, et al.
Publicado: (2020)

RV dysfunction in Covid-19 ARDS: Is there a difference in the impact of mechanical ventilation and ECMO?
por: Tsolaki, Vasiliki, et al.
Publicado: (2021)

Dynamic hyperinflation and intrinsic PEEP in ARDS patients: who, when, and how needs more focus?
por: Wang, Heyan, et al.
Publicado: (2019)

Reply to: RV dysfunction in Covid-19 ARDS: Is there a difference in the impact of mechanical ventilation and ECMO?
por: Bleakley, Caroline, et al.
Publicado: (2021)

Ability of the respiratory ECMO survival prediction (RESP) score to predict survival for patients with COVID-19 ARDS and non-COVID-19 ARDS: a single-center retrospective study
por: Pratt, Elias H., et al.
Publicado: (2023)

Witnessing consciousness
por: Krishnacharya, Prabhakar Srinivasapuram
Publicado: (2016)

Regional referral ECMO centre decision and mid-term mortality of patients suffering severe Acute Respiratory Distress Syndrome (ARDS)
por: Rozé, Hadrien, et al.
Publicado: (2020)

Morbidly obese with severe ARDS: ECMO or no ECMO?
por: Shalaby, Mohammed A.
Publicado: (2017)

Central nervous system reactivation of herpesviridae family in patients with COVID-19
por: Haddad, Mahboubeh, et al.
Publicado: (2023)

SARS-CoV-2 infection as a risk factor for herpesviridae reactivation: consider the potential influence of corticosteroid therapy
por: Honore, Patrick M., et al.
Publicado: (2020)

COVID-19 infection and vaccines: potential triggers of Herpesviridae reactivation()
por: Navarro-Bielsa, Alba, et al.
Publicado: (2023)

To prone or not to prone ARDS patients on ECMO
por: Roca, Oriol, et al.
Publicado: (2021)

Explanation of Criminality
por: Line, Maurice B.
Publicado: (1962)

Ultrasound witnessed cardiac arrest in the ICU
por: Adkins, Eric J., et al.
Publicado: (2014)

ECMO for ARDS due to COVID-19
por: Ñamendys-Silva, Silvio A.
Publicado: (2020)

Characteristics and Outcomes of Severe ARDS Patients Receiving ECMO in Southern Thailand
por: Assanangkornchai, Nawaporn, et al.
Publicado: (2019)

Re: Insight into ECMO, mortality and ARDS: a nationwide analysis of 45,647 ECMO runs (Friedrichson et al., Critical Care, January 2021)
por: Warren, Alex, et al.
Publicado: (2021)

vvECMO can be avoided by a transpulmonary pressure guided open lung concept in patients with severe ARDS
por: van der Zee, Philip, et al.
Publicado: (2019)

Child-witnessed domestic violence: An epidemic in the shadows
por: Tsavoussis, Areti, et al.
Publicado: (2015)

Fulminant myocarditis in COVID-19 and favorable outcomes with VA-ECMO
por: Bhardwaj, Abhishek, et al.
Publicado: (2022)

RESPIRATORY PHYSIOLOGICAL PARAMETERS AND OUTCOMES OF PATIENTS WITH COVID-19 ARDS AND NON-COVID-19 ARDS UNDERGOING ECMO
por: FEDERBUSH, M., et al.
Publicado: (2022)

Breast implant extrusion related to Herpesviridae
por: Thayabaran, Darmiga, et al.
Publicado: (2015)

Successful repeat ECMO in a patient with AIDS and ARDS
por: Horikita, Sho, et al.
Publicado: (2017)

Spontaneous hemothorax in 4 COVID-19 ARDS patients on VV-ECMO revealing pulmonary artery aneurysms
por: Desnos, Cyrielle, et al.
Publicado: (2020)

Efficacy of Acyclovir to Suppress Herpes Simplex Virus Oropharyngeal Reactivation in Patients Who Are Mechanically Ventilated: An Ancillary Study of the Preemptive Treatment for Herpesviridae (PTH) Trial
por: Luyt, Charles-Edouard, et al.
Publicado: (2021)

OUTCOMES OF WHITE VS MINORITY PATIENTS WITH COVID-19 WITH ARDS TREATED WITH ECMO
por: REDDY, RENUKA, et al.
Publicado: (2021)

ECMO, ARDS and AH1N1
por: Zangrillo, A
Publicado: (2009)

ECMO and endogenous carboxyhemoglobin formation
por: Tripathi, Ravi S, et al.
Publicado: (2011)

Thoracoabdominal impalement with criminal intent
por: Barbosa, Antonio Gabriel de Jesus, et al.
Publicado: (2018)

Herpes simplex virus and Cytomegalovirus reactivation among severe ARDS patients under veno-venous ECMO
por: Hraiech, Sami, et al.
Publicado: (2019)

Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah’s Witness patient
por: Schlaweck, Sebastian, et al.
Publicado: (2021)

Adjunctive corticosteroids may be associated with better outcome for non-HIV Pneumocystis pneumonia with respiratory failure: a systemic review and meta-analysis of observational studies
por: Ding, Lin, et al.
Publicado: (2020)

Thrombotic thrombocytopenic purpura treated with vincristine in a Jehovah's witness
por: Walia, Sandeep S., et al.
Publicado: (2011)

The stance of Jehovah's Witnesses on the use blood and Hospital Liaison Committee
por: Lee, Jong Hyun, et al.
Publicado: (2011)

Insight into ECMO, mortality and ARDS: a nationwide analysis of 45,647 ECMO runs
por: Friedrichson, Benjamin, et al.
Publicado: (2021)

What is New in ECMO for COVID-19?
por: Furzan, Alberto, et al.
Publicado: (2023)

Normalizing the Abnormal: Hypoxemia in Venovenous ECMO
por: Ortoleva, Jamel P., et al.
Publicado: (2022)

Herpesviridae prevalence in aqueous humor using PCR
por: Keorochana, Narumon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ggp7k0fann99pu8flbr1e3p769